Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14501718rdf:typepubmed:Citationlld:pubmed
pubmed-article:14501718lifeskim:mentionsumls-concept:C0138741lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C0618743lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C1996904lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C0439810lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C1880497lld:lifeskim
pubmed-article:14501718lifeskim:mentionsumls-concept:C0281186lld:lifeskim
pubmed-article:14501718pubmed:issue4 Pt 1lld:pubmed
pubmed-article:14501718pubmed:dateCreated2003-9-22lld:pubmed
pubmed-article:14501718pubmed:abstractTextWe investigated the value of serum measurements for glandular kallikrein 2 (hK2), and free (f) and total (t) prostate specific antigen (PSA) in a second round of biannual screening for prostate cancer.lld:pubmed
pubmed-article:14501718pubmed:languageenglld:pubmed
pubmed-article:14501718pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14501718pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14501718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14501718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14501718pubmed:statusMEDLINElld:pubmed
pubmed-article:14501718pubmed:monthOctlld:pubmed
pubmed-article:14501718pubmed:issn0022-5347lld:pubmed
pubmed-article:14501718pubmed:authorpubmed-author:HugossonJonas...lld:pubmed
pubmed-article:14501718pubmed:authorpubmed-author:LiljaHansHlld:pubmed
pubmed-article:14501718pubmed:authorpubmed-author:PetterssonKim...lld:pubmed
pubmed-article:14501718pubmed:authorpubmed-author:PiironenTimoTlld:pubmed
pubmed-article:14501718pubmed:authorpubmed-author:BeckerCharlot...lld:pubmed
pubmed-article:14501718pubmed:issnTypePrintlld:pubmed
pubmed-article:14501718pubmed:volume170lld:pubmed
pubmed-article:14501718pubmed:ownerNLMlld:pubmed
pubmed-article:14501718pubmed:authorsCompleteYlld:pubmed
pubmed-article:14501718pubmed:pagination1169-74lld:pubmed
pubmed-article:14501718pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:meshHeadingpubmed-meshheading:14501718...lld:pubmed
pubmed-article:14501718pubmed:year2003lld:pubmed
pubmed-article:14501718pubmed:articleTitleTesting in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.lld:pubmed
pubmed-article:14501718pubmed:affiliationDepartment of Clinical Chemistry, Lund University, University Hospital Malmö, Sweden. charlotte.becker@klkemi.mas.lu.selld:pubmed
pubmed-article:14501718pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14501718pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14501718lld:pubmed